Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-Current Assets (2016 - 2025)

OptimizeRx's Non-Current Assets history spans 16 years, with the latest figure at $114.0 million for Q3 2025.

  • For Q3 2025, Non-Current Assets fell 3.5% year-over-year to $114.0 million; the TTM value through Sep 2025 reached $462.4 million, up 291.46%, while the annual FY2024 figure was $117.2 million, 9.07% down from the prior year.
  • Non-Current Assets for Q3 2025 was $114.0 million at OptimizeRx, down from $115.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $128.9 million in Q4 2023 and bottomed at $25.4 million in Q1 2022.
  • The 5-year median for Non-Current Assets is $36.5 million (2023), against an average of $69.1 million.
  • The largest annual shift saw Non-Current Assets surged 257.3% in 2023 before it decreased 9.23% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $25.9 million in 2021, then soared by 39.43% to $36.1 million in 2022, then soared by 257.3% to $128.9 million in 2023, then decreased by 9.07% to $117.2 million in 2024, then fell by 2.73% to $114.0 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Non-Current Assets are $114.0 million (Q3 2025), $115.2 million (Q2 2025), and $116.1 million (Q1 2025).